Gold plunges 4% as stocks jump on COVID-19 vaccine euphoria (Reuters)

(Reuters) - Gold slumped more than 4% on Monday as news of the first successful late-stage COVID-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets instead.